Molecular insights into the interplay between type 2 diabetes mellitus and osteoporosis: implications for endocrine health
- PMID: 39897963
- PMCID: PMC11782046
- DOI: 10.3389/fendo.2024.1483512
Molecular insights into the interplay between type 2 diabetes mellitus and osteoporosis: implications for endocrine health
Abstract
Background: Type 2 diabetes mellitus (T2DM) and osteoporosis are prevalent, interconnected chronic diseases that significantly impact global health. Understanding their complex biological relationship is crucial for improving patient outcomes and treatment strategies.
Method: This review examines recent research on the mechanisms linking T2DM with osteoporosis. It focuses on how abnormalities in bone metabolism, autophagy, ferroptosis, and vitamin D receptor (VDR) gene polymorphisms contribute to osteoporosis in T2DM patients.
Results: Our analysis indicates that T2DM is associated with reduced bone formation and increased bone resorption, which are influenced by hormonal changes, inflammation, and disrupted cellular signaling pathways. Additionally, increased perirenal fat thickness worsens osteoporosis through local inflammation and altered adipokine levels. VDR gene polymorphisms provide new molecular insights into this connection.
Conclusion: Addressing the identified mechanisms with targeted management strategies may improve bone health in individuals with T2DM. Future research should explore these associations in greater detail to develop more effective prevention and treatment strategies.
Keywords: autophagy; bone metabolism; ferroptosis; osteoporosis; perirenal fat thickness; type 2 diabetes mellitus; vitamin D receptor gene polymorphism.
Copyright © 2025 Jiang, Song, Yan, Liu, Qiao and Zhang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Mao X, Li X, Hu W, Hao S, Yuan Y, Guan L, Guo B, et al. . Retraction: Downregulated brain and muscle aryl hydrocarbon receptor nuclear translocator-like protein-1 inhibits osteogenesis of BMSCs through p53 in type 2 diabetes mellitus. Biology Open (2022) 11:bio058581. doi: 10.1242/bio.058581 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
